US5401509A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Pharmaceutical compositions and methods of treatment of the cornea in conjunction with laser irradiation
Assignee: Alcon Research LLC
•
Filing: 1994-07-25
•
Granted: 1995-03-28
•
Expires: 2014-07-25
Abstract
Abstract Methods for preventing and treating corneal haze resulting from exposure of the eye to laser irradiation are disclosed. The methods include administration of compositions of wound healing modulators to the eye. Compositions for use in preventing and treating the corneal haze are also disclosed.
Inventors
- 👤 Stella M. Robertson
- 👤 Herman M. Kunkle, Jr.
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 18:46
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0048; A61K31/00; A61K31/557; A61K31/5575; A61K31/558; A61K31/56; A61K31/57; A61K38/00; A61K38/04; A61K38/12
Claims Analysis
Total Claims: 11
Claim 1
Independent Claim
41 words
A method for treating a cornea in conjunction with laser irradiation and resulting photoablation and volumetric removal of corneal tissue, comprising: applying to the affected cornea a composition containing an antiinflammatory effective amount of asteroid and a pharmaceutically acceptable carrier therefor.
Claim 2
Independent Claim
41 words
A method for treating a cornea in conjunction with laser irradiation and resulting photoablation and volumetric removal of corneal tissue, comprising: applying to the affected cornea a composition containing an antiinflammatory effective amount of asteroid and a pharmaceutically acceptable carrier therefor.
Claim 3
Dependent Claim
10 words
The composition of claim 1 wherein the steroid comprises dexamethasone.
Claim 4
Dependent Claim
10 words
The composition of claim 1 wherein the steroid comprises fluorometholone.
Claim 5
Dependent Claim
10 words
The composition of claim 1 wherein the steroid comprises rimexolone.
Claim 6
Dependent Claim
10 words
The composition of claim 1 wherein the steroid comprises prednisolone.
Claim 7
Dependent Claim
10 words
The composition of claim 1 wherein the steroid comprises prednisone.
Claim 8
Dependent Claim
10 words
The composition of claim 1 wherein the steroid comprises medrysone.
Claim 9
Dependent Claim
10 words
The composition of claim 1 wherein the steroid comprises betamethasone.
Claim 10
Dependent Claim
10 words
The composition of claim 1 wherein the steroid comprises triamcinolone.
Claim 11
Dependent Claim
10 words
The composition of claim 1 wherein the steroid comprises hydrocortisone.
References Cited (Backward Citations)
US4454151A
Cited
US4438272A
Cited
US4436745A
Cited
US4599353A
Cited
US4559343A
Cited
US4474751A
Cited
GB2144993A
Cited
EP0140998A1
Cited
US4665913A
Cited
US4732148A
Cited
US4717725A
Cited
US4600717A
Cited
US4717727A
Cited
WO1986002271A1
Cited
US4966911A
Cited
EP0189272A2
Cited
EP0190018A2
Cited
US4797422A
Cited
US4686214A
Cited
US4692460A
Cited
US5036056A
Cited
US4939135A
Cited
US5124392A
Cited
US5098896A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1998-03-27 | 1998-09-26 | 1999-03-28 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2002-03-27 | 2002-09-26 | 2003-03-28 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2006-03-27 | 2006-09-26 | 2007-03-28 | $7700.00 | Window Closed / Lapsed |